| pubmed-article:1723011 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1723011 | lifeskim:mentions | umls-concept:C0400447 | lld:lifeskim |
| pubmed-article:1723011 | lifeskim:mentions | umls-concept:C0003641 | lld:lifeskim |
| pubmed-article:1723011 | lifeskim:mentions | umls-concept:C0392747 | lld:lifeskim |
| pubmed-article:1723011 | lifeskim:mentions | umls-concept:C0427579 | lld:lifeskim |
| pubmed-article:1723011 | lifeskim:mentions | umls-concept:C0441509 | lld:lifeskim |
| pubmed-article:1723011 | lifeskim:mentions | umls-concept:C0750729 | lld:lifeskim |
| pubmed-article:1723011 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:1723011 | pubmed:dateCreated | 1992-3-4 | lld:pubmed |
| pubmed-article:1723011 | pubmed:abstractText | The changes in relevant haemostatic parameters during the course of ten orthotopic liver transplantation were studied when aprotinin was given intra-operatively. Increases of tissue-type (P = 0.008) and urokinase-type (P = 0.009) plasminogen activators during the anhepatic phase could be correlated with hyperfibrinolysis. Thrombin-antithrombin III complexes (TAT) increased after revascularization of the liver graft (P = 0.003). Parallel studies in the perfusate showed that TAT concentrations were 350% and protease inhibitor activities (antithrombin III, protein C) only 52% of the systemic circulation before reperfusion, suggesting that thrombin activation together with protease inhibitor consumption occurs during graft liver reperfusion. The relatively smaller increases in profibrinolytic parameters and a lower blood loss when compared with other groups may be explained by aprotinin administration in our patients. | lld:pubmed |
| pubmed-article:1723011 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1723011 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1723011 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1723011 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1723011 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1723011 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1723011 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1723011 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1723011 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1723011 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1723011 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1723011 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:1723011 | pubmed:issn | 0957-5235 | lld:pubmed |
| pubmed-article:1723011 | pubmed:author | pubmed-author:NeuhausPP | lld:pubmed |
| pubmed-article:1723011 | pubmed:author | pubmed-author:JochumMM | lld:pubmed |
| pubmed-article:1723011 | pubmed:author | pubmed-author:RiessHH | lld:pubmed |
| pubmed-article:1723011 | pubmed:author | pubmed-author:HimmelreichGG | lld:pubmed |
| pubmed-article:1723011 | pubmed:author | pubmed-author:KierzekBB | lld:pubmed |
| pubmed-article:1723011 | pubmed:author | pubmed-author:SlamerK JKJ | lld:pubmed |
| pubmed-article:1723011 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1723011 | pubmed:volume | 2 | lld:pubmed |
| pubmed-article:1723011 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1723011 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1723011 | pubmed:pagination | 51-8 | lld:pubmed |
| pubmed-article:1723011 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:1723011 | pubmed:meshHeading | pubmed-meshheading:1723011-... | lld:pubmed |
| pubmed-article:1723011 | pubmed:meshHeading | pubmed-meshheading:1723011-... | lld:pubmed |
| pubmed-article:1723011 | pubmed:meshHeading | pubmed-meshheading:1723011-... | lld:pubmed |
| pubmed-article:1723011 | pubmed:meshHeading | pubmed-meshheading:1723011-... | lld:pubmed |
| pubmed-article:1723011 | pubmed:meshHeading | pubmed-meshheading:1723011-... | lld:pubmed |
| pubmed-article:1723011 | pubmed:meshHeading | pubmed-meshheading:1723011-... | lld:pubmed |
| pubmed-article:1723011 | pubmed:meshHeading | pubmed-meshheading:1723011-... | lld:pubmed |
| pubmed-article:1723011 | pubmed:meshHeading | pubmed-meshheading:1723011-... | lld:pubmed |
| pubmed-article:1723011 | pubmed:meshHeading | pubmed-meshheading:1723011-... | lld:pubmed |
| pubmed-article:1723011 | pubmed:meshHeading | pubmed-meshheading:1723011-... | lld:pubmed |
| pubmed-article:1723011 | pubmed:meshHeading | pubmed-meshheading:1723011-... | lld:pubmed |
| pubmed-article:1723011 | pubmed:meshHeading | pubmed-meshheading:1723011-... | lld:pubmed |
| pubmed-article:1723011 | pubmed:meshHeading | pubmed-meshheading:1723011-... | lld:pubmed |
| pubmed-article:1723011 | pubmed:meshHeading | pubmed-meshheading:1723011-... | lld:pubmed |
| pubmed-article:1723011 | pubmed:year | 1991 | lld:pubmed |
| pubmed-article:1723011 | pubmed:articleTitle | Coagulation changes and the influence of the early perfusate in the course of orthotopic liver transplantation (OLT) when aprotinin is used intra-operatively. | lld:pubmed |
| pubmed-article:1723011 | pubmed:affiliation | Department of Internal Medicine, Universitätsklinikum Rudolf Virchow, Berlin, Germany. | lld:pubmed |
| pubmed-article:1723011 | pubmed:publicationType | Journal Article | lld:pubmed |
